Future directions include, but are not limited to, in vivo verification of GRP78 and UPR pathways in rifampicin-treated PD animal models, investigation of the functions of GRP78 proteins in ER stress and how they are regulated, identification of other potential therapeutic targets. Here, HSPA5 is linked to Parkinson disease.